Showing results (1-10 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjectsS Emery, C Workman, R L Puls, et al.Human Vaccines|October 3, 2006
Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posologyEva Maria Pöllabauer, Robert Petermann, Hartmut J EhrlichHuman Vaccines|October 3, 2006
Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvantPhilip M Levesque, Kimberly Foster, Uditha de AlwisHuman Vaccines|October 3, 2006
Hospitalization by pneumonia and influenza in the 50-64 year old population in Spain (1999-2002)Angel Gil, Ruth Gil, Itziar Oyagüez, et al.Human Vaccines|October 3, 2006
Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adultsCatherine M Dentinger, Thomas W Hennessy, Lisa R Bulkow, et al.Human Vaccines|October 3, 2006
States' emergency orders regarding the 2004-05 influenza vaccine shortageMichael A Gaglia, Matthew M DavisHuman Vaccines|October 3, 2006
Tuberculin purified protein derivative (PPD) immunoassay as an in vitro alternative assay for identity and confirmation of potencyMei M Ho, Satnam K Kairo, Michael J CorbelHuman Vaccines|October 3, 2006
Comparison of rabbit and mouse models for persistence analysis of plasmid-based vaccinesVicky L Leamy, Terrie Martin, Rohit Mahajan, et al.Human Vaccines|March 11, 2011
The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010Nicole Guiso, Johannes Liese, Stanley PlotkinHuman Vaccines|March 11, 2011
Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapyDae-Sun Kim, Jae-Hwan NamPageof 64